Salinomycin attenuates liver cancer stem cell motility by enhancing cell stiffness and increasing F-actin formation via the FAK-ERK1/2 signalling pathway
- Resource Type
- Article
- Source
- In
Toxicology 1 June 2017 384:1-10 - Subject
- Language
- ISSN
- 0300-483X